AVI BioPharma, Inc. (NASDAQ:AVII)
| CAPS Rating |
|
|---|---|
| Open | $1.19 |
| Previous Close | $1.20 |
| Daily Range | $1.00 - $1.19 |
| 52-Week Range | $0.50 - $2.17 |
| Market Cap | $150.64M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,175,602 |
| Average Daily Volume | 0 |
AVII
VS S&P 500 (SPY)
How do you think AVII will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AVII Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AVII News and Commentary
- 3 Stocks Stopping the Presses – The Motley Fool
- Why Did My Stock Just Fall Apart? – The Motley Fool
- 9 Small Biotechs Near 52-Week Lows – The Motley Fool
- 7 Hot Penny Stocks to Buy Now – NASDAQ
- 3 Telling Insider Trades Worth Investigating – SeekingAlpha
- 4 Stocks With Recent CEO Insider Buys of at least $150,000 – SeekingAlpha
- 6 Stocks Reporting Substantial Insider Buying – SeekingAlpha
- AVI BioPharma: Recent Fund-Raising Not a Competitive Entry Point – SeekingAlpha
- These Cold Stocks Are Heating Up – The Motley Fool
- 12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors – The Motley Fool
- Biotech and Drug Stocks Are Hot – SeekingAlpha
- Wall Street's Best Hidden Stocks – The Motley Fool
- 4-Star Stocks Poised to Pop: Isis Pharmaceuticals – The Motley Fool
- Early Market-Movers: ZymoGenetics, Microtune – Fox Business
- Biotech: Update on Deals, Mergers, Funding – SeekingAlpha
- 3 Stocks Springing Back – The Motley Fool
- UPDATE 1-AVI BioPharma gives positive muscle drug clinical data – Reuters
- UPDATE 1-AVI genetic disorder drug gets orphan status in EU – Reuters
- 4-Star Stocks on the Upswing – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
RSS Headlines
Fool UK
